Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 521 of 521 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/01
End: 12/31/03
Due: 12/31/04
Phase: N/A
Priority: Normal
Start: 03/08/07
End: 03/03/15
Due: 03/03/16
Phase: N/A
Priority: Normal
Start: 02/28/06
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 08/31/04
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 12/31/00
End: 07/31/01
Due: 07/31/02
Phase: N/A
Priority: Normal
Start: 12/31/02
End: 02/28/03
Due: 02/28/04
Phase: N/A
Priority: Normal
Start: 04/30/99
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 10/02/17
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 04/13/15
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 12/31/00
End: 01/31/03
Due: 01/31/04
Phase: N/A
Priority: Normal
Start: 11/18/09
End: 03/10/10
Due: 03/10/11
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 07/31/14
Due: 07/31/15
A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 09/30/08
Due: 09/30/09
Phase: N/A
Priority: Normal
Start: 07/25/14
End: 11/28/17
Due: 11/28/18
Phase: N/A
Priority: Normal
Start: 11/13/07
End: 09/01/08
Due: 09/01/09
Phase: N/A
Priority: Normal
Start: 09/02/19
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/30/01
End: 01/31/06
Due: 01/31/07
Phase: N/A
Priority: Normal
Start: 04/16/24
End: 04/30/27
Due: 04/30/28
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 08/31/08
Due: 08/31/09